You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune modulator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Ischemic Stroke Trial (Dimethyl fumarate, Placebo)

Not yet recruiting
  • Acute Ischemic Stroke
  • Dimethyl fumarate
  • Placebo
  • (no location specified)
May 17, 2021

Acute Ischemic Stroke Trial (Dimethyl Fumarate, Placebo)

Not yet recruiting
  • Acute Ischemic Stroke
  • Dimethyl Fumarate
  • Placebo
  • (no location specified)
May 17, 2021

Stroke, Inflammation Trial in Hangzhou (Fingolimod)

Withdrawn
  • Stroke
  • Inflammation
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Jul 15, 2021

Stroke, Inflammation Trial in Hangzhou (Fingolimod, Placebo)

Unknown status
  • Stroke
  • Inflammation
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Jul 17, 2021

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Infections, Covid19, Cancer Trial in San Sebastián de los Reyes (Rosmalip®, Placebo)

Enrolling by invitation
  • Infections
  • +2 more
  • Rosmalip®
  • Placebo
  • San Sebastián de los Reyes, Madrid, Spain
    Servicio de Oncología. Hospital Infanta Sofía.
Oct 5, 2021

Heart Diseases Trial in Johnson City (Exercise training)

Completed
  • Heart Diseases
  • Exercise training
  • Johnson City, Tennessee
    James H. Quillen College of Medicine
Dec 10, 2019

Chronic Hepatitis B Trial in Worldwide (RO7062931, Placebo, Immune Modulator)

Completed
Has Results
  • Chronic Hepatitis B
  • Parkville, Victoria, Australia
  • +18 more
Nov 30, 2020

DLBCL Trial in Worldwide (biological, other, drug)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Avelumab
  • +6 more
  • Duarte, California
  • +29 more
Nov 20, 2020

Immune Checkpoint Inhibitors Rechallenge After Immune-related

Unknown status
  • Cancer
  • Immune Checkpoint Modulator
  • Caen, Basse Normandie, France
    Alexandre Joachim
Nov 17, 2019

COVID-19 Trial in Minneapolis (abatacept infusion, Placebo group)

Not yet recruiting
  • COVID-19
  • abatacept infusion
  • Placebo group
  • Minneapolis, Minnesota
    University of Minnesota
Apr 18, 2023

ive Modulator Therapy on the Cystic Fibrosis Microbiome

Not yet recruiting
  • Cystic Fibrosis
  • Nasal endoscopy with microbiome swab and mucus collection through filter paper and sponge
  • +2 more
  • (no location specified)
Aug 1, 2023

Sepsis, Septic Shock, Immunoinflammatory Response Trial in Tunis (Erythromycin)

Recruiting
  • Sepsis
  • +2 more
  • Tunis, Tunisia
    intensive care unit of the University Hospital Center La Rabta
Apr 26, 2022

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    N\L Ratio Versus L\A Ratio asPredictor of Morbidity and

    Recruiting
    • Sepsis
    • Neutrophil/Lymphocyte ratio and lactate/ albumin ratio will be measured in all patients.
    • Tanta, Egypt
      Tanta U
    Apr 21, 2023

    Vitamin D on Hashimoto's Thyroiditis

    Not yet recruiting
    • Hashimoto Thyroiditis
    • Vitamin D Drops
    • (no location specified)
    May 22, 2023

    Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

    Not yet recruiting
    • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +10 more
    • (no location specified)
    Jan 31, 2023

    Palate; Wound Trial (GeliO3, Gingi gel)

    Not yet recruiting
    • Palate; Wound
    • (no location specified)
    Jan 22, 2023

    NSCLC Trial in Goyang-Si (CA and Nivolumab)

    Recruiting
    • Non-small Cell Lung Cancer
    • CA and Nivolumab
    • Goyang-Si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Apr 4, 2022

    Healthy Trial in Merksem (Adalimumab, Lipopolysaccharide (LPS))

    Recruiting
    • Healthy
    • Merksem, Belgium
      Clinical Pharmacology Unit
    May 22, 2023

    Disinfectant Causing Toxic Effect Trial (Alcohol sterilization, Honey sterilization)

    Not yet recruiting
    • Disinfectant Causing Toxic Effect
    • Alcohol sterilization
    • Honey sterilization
    • (no location specified)
    Jul 6, 2023

    iMmune Function in Post-surgical and AuToimmune

    Completed
    • Hypoparathyroidism
    • +2 more
      • Rome, Italy
        Department of Experimental Medicine, "Sapienza" University of Ro
      Dec 4, 2022

      Intestinal Inflammation in People With Primary Immune

      Recruiting
      • Chronic Granulomatous Disease
      • Inflammatory Bowel Disease
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Myocarditis Acute, Cancer Trial in Boston (Abatacept plus, Placebo)

        Recruiting
        • Myocarditis Acute
        • Cancer
        • Abatacept plus
        • Placebo
        • Los Angeles, California
        • +16 more
        Feb 1, 2023

        Chronic Fatigue Syndrome Trial in Incline Village, Charlotte (Poly I: Poly C12U (Rintatolimod))

        Available
        • Chronic Fatigue Syndrome
        • Poly I: Poly C12U (Rintatolimod)
        • Incline Village, Nevada
        • +1 more
        Apr 29, 2022